MINNEAPOLIS, Jan. 8, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced it will showcase its new ProPak™ GMP cytokines, alongside its portfolio of innovative products and solutions supporting cell and gene therapy development and manufacturing at Phacilitate's Advanced Therapies Week, taking place January 20-23 at the Kay Bailey Hutchison Convention Center in Dallas, Texas.Bio-Techne will feature its cell and gene therapy workflow reproducibility and scalability solutions, including ...

Core Insights - Bio-Techne Corporation has announced a partnership with MedSanTek to distribute its brands in Turkey, enhancing its market presence in the region [1][3] - MedSanTek is recognized as a leading distributor in in vitro diagnostics and research products, serving Turkey and Azerbaijan, and is known for its high-quality solutions in various scientific fields [2][3] - The partnership aims to leverage MedSanTek's local expertise and Bio-Techne's innovative product portfolio to advance scientific research and healthcare in Turkey and Azerbaijan [3] Company Overview - Bio-Techne Corporation is a global life sciences company that provides innovative tools and bioactive reagents for research and clinical diagnostics, generating approximately $1.2 billion in net sales in fiscal 2024 [4] - The company employs around 3,100 people worldwide and offers a vast portfolio of products that assist in scientific investigations and drug discovery [4]

Core Insights - BIO-key International, Inc. has entered into an agreement with Fiber Food Systems, Inc. to enhance security and operational efficiency in the food service sector through the integration of identity and access management (IAM) solutions [1][2][3] Company Overview - BIO-key specializes in workforce and customer identity and access management solutions, focusing on Identity-Bound Biometrics for secure authentication experiences [1][8] - Fiber Food Systems is dedicated to global food security and innovation in food technology, producing high-demand consumer packaged goods and plant-based proteins [1][9] Transaction Details - BIO-key acquired 5,000,000 shares of Boumarang, Inc. from Fiber in exchange for 595,000 shares of BIO-key, representing 19% of BIO-key's issued shares, strengthening its balance sheet with an additional $5 million in net assets [1] Strategic Collaboration - The partnership aims to combine BIO-key's IAM expertise with Fiber's food technology, enhancing security and streamlining access in high-traffic environments such as schools and universities [2][3] - BIO-key's PortalGuard IAM platform supports over 35 million users with phoneless, tokenless, and passwordless access options, which will be integrated into Fiber's food service operations [2][8] Innovation and Growth Opportunities - The collaboration is expected to improve operational efficiency in time-sensitive food service environments by deploying biometric authentication [4] - BIO-key's scalable IAM solutions will allow Fiber to implement tailored security measures across its expanding food tech and distribution network [5] - The partnership reflects a commitment to innovation in the food tech sector, setting a benchmark for safety and efficiency in food service technology [6] Leadership Statements - The CEO of BIO-key emphasized the importance of delivering secure IAM solutions to industries requiring seamless access, particularly in food services [7] - The Executive Chairperson of Fiber highlighted the alignment of their mission with BIO-key's technology to transform the food tech industry [7]

MINNEAPOLIS, Nov. 27, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Kim Kelderman, President and Chief Executive Officer, will present at the Citi 2024 Global Healthcare Conference on Wednesday, December 4, 2024, at 3:15 p.m. EST. A live webcast of the presentation can be accessed via the IR Calendar page of Bio-Techne's Investor Relations website at https://investors.bio-techne.com/ir-calendar.About Bio-TechneBio-Techne Corporation (NASDAQ: TECH) is a global life sciences ...

MINNEAPOLIS, Nov. 20, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities today announced a partnership with Leader Life Sciences. Under the agreement, Leader Life Sciences becomes a distributor of Bio-Techne's portfolio across the Gulf Cooperation Council (GCC) countries, which include Bahrain, Oman, Qatar, Saudi Arabia, and United Arab Emirates.Founded in 2020, Lead ...

MINNEAPOLIS, Nov. 18, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced a strategic partnership with ALZpath, Inc to accelerate breakthroughs in neurodegenerative disease research and treatment, including Alzheimer's disease. The collaboration leverages Bio-Techne's Ella™ fully automated, multiplexing immunoassay platform and ALZpath's proprietary pTau217 antibody to provide the Simple Plex Human Phospho-Tau (T217) ALZpath Assay. ALZpath The ALZpath pTau217 (phosphorylated Tau2 ...

HOLMDEL, N.J., Nov. 14, 2024 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (Nasdaq: BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) solutions featuring passwordless, phoneless and token-less Identity-Bound Biometric (IBB) authentication, announced results for its third quarter ended September 30, 2024 (Q3’24). BIO-key’s 2023 Q3 and nine month results were restated and filed with the Company’s 2023 Form 10-K and are reflected in this release. BIO-key will host ...

Customers will present data from their use of novel assays and kits; company will host educational workshops and discussions for attendeesMINNEAPOLIS, Nov. 14, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced its lineup of presentations and activities for the Association for Molecular Pathology (AMP) 2024 Annual Meeting & Expo, taking place November 19-23 in Vancouver, British Columbia. Asuragen, a Bio-Techne brand, will be exhibiting and showcasing its latest research products for ...

R&D Systems Hematology Controls and Calibrators has completed the Class B Certification under the new European Union In Vitro Diagnostic RegulationThis press release updates the IVDR Classification to Class B from the prior Class C. MINNEAPOLIS, Nov. 11, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) has recently achieved In Vitro Diagnostic Regulation (IVDR) certification for its R&D Systems Hematology Controls and Calibrators. This certification confirms that the products comply with the regul ...

R&D Systems Hematology Controls and Calibrators has completed the Class C Certification under the new European Union In Vitro Diagnostic RegulationMINNEAPOLIS, Nov. 11, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) has recently achieved In Vitro Diagnostic Regulation (IVDR) certification for its R&D Systems Hematology Controls and Calibrators. This certification confirms that the products comply with the regulations and guidelines set forth by the European Union for in-vitro diagnostic devices. ...